Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PLX

Pyrolyx (PLX)

Pyrolyx AG
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:PLX
DateTimeSourceHeadlineSymbolCompany
16/11/201300:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest EliminationsASX:PLXProtalix BioTherapeutics Inc.
16/11/201300:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-ASX:PLXProtalix BioTherapeutics Inc.
16/11/201300:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-ASX:PLXProtalix BioTherapeutics Inc.
16/11/201300:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest SalesASX:PLXProtalix BioTherapeutics Inc.
16/11/201300:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest PurchasesASX:PLXProtalix BioTherapeutics Inc.
16/11/201300:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-ASX:PLXProtalix BioTherapeutics Inc.
06/02/201310:43Dow Jones NewsU.S. HOT STOCKS: Zynga, Take-Two, Shutterfly Active in Late TradingASX:PLXProtalix BioTherapeutics Inc.
06/02/201306:21Dow Jones NewsU.S. HOT STOCKS: Yum Brands, McGraw-Hill, Virgin Media, OpexaASX:PLXProtalix BioTherapeutics Inc.
06/02/201304:40Dow Jones NewsProtalix Confirms It's Considering Options; Shares SurgeASX:PLXProtalix BioTherapeutics Inc.
11/06/201222:29Dow Jones NewsProtalix Gets $25 Million Milestone Payment For Rare-Disease DrugASX:PLXProtalix BioTherapeutics Inc.
02/05/201208:05Dow Jones NewsUPDATE: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseASX:PLXProtalix BioTherapeutics Inc.
02/05/201207:37Dow Jones NewsCORRECT: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseASX:PLXProtalix BioTherapeutics Inc.
02/05/201207:07Dow Jones NewsFDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseASX:PLXProtalix BioTherapeutics Inc.
16/10/200902:50Dow Jones NewsUPDATE: Protalix Gaucher's Treatment Passes Late-Stage TrialASX:PLXProtalix BioTherapeutics Inc.
15/10/200921:56Dow Jones NewsProtalix Gaucher's Treatment Passes Late-Stage TrialASX:PLXProtalix BioTherapeutics Inc.
01/09/200904:39Dow Jones NewsGenzyme Top Seller Faces Competition Amid Supply IssuesASX:PLXProtalix BioTherapeutics Inc.
25/08/200923:06Dow Jones NewsFDA Gives Fast-Track Status To Protalix Drug For Gaucher'sASX:PLXProtalix BioTherapeutics Inc.
17/08/200922:35Dow Jones NewsFDA OKs Protalix's Treatment Protocol Drug For Gaucher DiseaseASX:PLXProtalix BioTherapeutics Inc.
04/08/200901:54Dow Jones NewsIcagen Rallies, Genzyme Slides On FDA UpdatesASX:PLXProtalix BioTherapeutics Inc.
03/08/200917:05Dow Jones NewsShire Says FDA Permits Vela Use; Reports Phase III SuccessASX:PLXProtalix BioTherapeutics Inc.
16/07/200919:12Dow Jones NewsUPDATE: Shire Gets Fast-Track Approval For Gaucher-Treating DrugASX:PLXProtalix BioTherapeutics Inc.
16/07/200917:25Dow Jones NewsShire Gets Fast-Track Approval For Gaucher-Treating DrugASX:PLXProtalix BioTherapeutics Inc.
07/07/200919:11Dow Jones NewsUPDATE:Shire Seeks FDA OK To Provide Vela Amid Drug ShortageASX:PLXProtalix BioTherapeutics Inc.
 Showing the most relevant articles for your search:ASX:PLX